Compositions and methods for treating cns disorders
US-2026098053-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
La Daniel patents
La Daniel is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | La Daniel |
| Total patents | 32 |
| First publication | Feb 26, 2015 |
| Latest publication | Apr 9, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for treating cns disorders
US-2026078143-A1 · Mar 19, 2026 · US
C7 substituted oxysterols and methods of use thereof
US-2025388622-A1 · Dec 25, 2025 · US
Compositions and methods for treating CNS disorders
US-12421275-B2 · Sep 23, 2025 · US
C7 substituted oxysterols and methods of use thereof
US-12331070-B2 · Jun 17, 2025 · US
Compositions and methods for treating cns disorders
US-2025171492-A1 · May 29, 2025 · US
C7 substituted oxysterols and methods of use thereof
US-2024300995-A1 · Sep 12, 2024 · US
Compositions and methods for treating cns disorders
US-2024150393-A1 · May 9, 2024 · US
C7 substituted oxysterols and methods of use thereof
US-11926646-B2 · Mar 12, 2024 · US
Cyp46a1 inhibitors and methods of use thereof
US-2023312522-A1 · Oct 5, 2023 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for treating CNS disorders
US-11718642-B2 · Aug 8, 2023 · US
Compositions and methods for treating cns disorders
US-2023085354-A1 · Mar 16, 2023 · US
Compounds, compositions, and methods of use
US-2022332699-A1 · Oct 20, 2022 · US
Compositions and methods for treating cns disorders
US-2022315621-A1 · Oct 6, 2022 · US
Oxysterols and methods of use thereof
US-11279730-B2 · Mar 22, 2022 · US
C7 substituted oxysterols and methods of use thereof
US-2022081465-A1 · Mar 17, 2022 · US
C7 substituted oxysterols and methods of use thereof
US-11149056-B2 · Oct 19, 2021 · US
Oxysterols and methods of use thereof
US-2021147468-A1 · May 20, 2021 · US
Compositions and methods for treating cns disorders
US-2021101928-A1 · Apr 8, 2021 · US
Compositions and methods for treating cns disorders
US-2020354399-A1 · Nov 12, 2020 · US
Oxysterols and methods of use thereof
US-10781231-B2 · Sep 22, 2020 · US
Pyridine sulfonamides
US-10668067-B2 · Jun 2, 2020 · US
Oxysterols and methods of use thereof
US-2020123195-A1 · Apr 23, 2020 · US
C7 substituted oxysterols and methods of use thereof
US-2020024300-A1 · Jan 23, 2020 · US
Oxysterols and methods of use thereof
US-2020002371-A1 · Jan 2, 2020 · US
Pyridine sulfonamides
US-2019167682-A1 · Jun 6, 2019 · US
Bicyclic sulfonamide compounds as sodium channel inhibitors
US-9458152-B2 · Oct 4, 2016 · US
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
US-9346798-B2 · May 24, 2016 · US
Bicyclic sulfonamide compounds as sodium channel inhibitors
US-2016046626-A1 · Feb 18, 2016 · US
Bicyclic sulfonamide compounds as sodium channel inhibitors
US-9212182-B2 · Dec 15, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sage Therapeutics Inc | 24 |
| Amgen Inc | 8 |
Top CPC classifications
Most common classification codes across this inventor's patents.